Rydex Series S&P MidCap 400 Pure Growth Fund

Scorecard
4 / 5 Stars
Lipper
5 5 3 1 4
Zacks Investment Research
2 (Buy)
Standard & Poor's
3 / 5 Stars
TheStreet.com
B- (Buy)

#41 in Mid-Cap Growth

U.S. News evaluated 223 Mid-Cap Growth Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Rydex Funds funds

See full Mid-Cap Growth rankings

See more fund rankings

Performance

The fund has returned 28.91 percent over the past year, 14.12 percent over the past three years, 30.34 percent over the past five years, and 10.77 percent over the past decade.

Trailing Returns Updated 02.28.2014
Year to date 1.2%
1 Year 28.9%
3 Years (Annualized) 14.1%
5 Years (Annualized) 30.3%
10 Years (Annualized) 10.8%

See more RYMGX performance

Summary

The investment seeks investment results that match, before fees and expenses, the performance of the S&P MidCap 400 Pure Growth Index for mid-cap growth securities on a daily basis. The fund employs as its investment strategy a program of investing in the common stock of companies that are within the capitalization range of the underlying index and derivative instruments. It will invest at least 80% of its net assets, plus any borrowings for investment purposes, in securities of companies in the underlying index and derivatives and other instruments whose performance is expected to correspond to that of the underlying index. The fund is non-diversified.

Fees

Fees are Low compared to funds in the same category.
Rydex Series S&P MidCap 400 Pure Growth Fund has an expense ratio of 1.50 percent.

See more RYMGX fees

Risk

Risk is Above Average compared to funds in the same category according to Morningstar.

See more RYMGX risk